StockData
Cerenome, Inc. logo

Cerenome, Inc. (CNSY) stock

CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.63−0.08 (-11.82%)

Close on Nov 17, 2026Market cap $4.78MP/E –Yield –

Cerenome cash

Cash and short-term investments held at the end of each period.

Cerenome's cash was $8.59M at Jun 30, 2026. For fiscal 2025 it was $13.10M, up 263.3% from the year before. Over ten years it grew -7.5% a year on average. The highest annual figure on record is $67.57M in fiscal 2011.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$13.10M+263.3%
FY2024Dec 31, 2024$3.61M-57.8%
FY2023Dec 31, 2023$8.55M-52.8%
FY2022Dec 31, 2022$18.12M-1.5%
FY2021Dec 31, 2021$18.40M+120.5%
FY2020Dec 31, 2020$8.35M-52.4%
FY2019Dec 31, 2019$17.55M+233.6%
FY2018Dec 31, 2018$5.26M-44.9%
FY2017Dec 31, 2017$9.55M-24.2%
FY2016Dec 31, 2016$12.60M-56.1%
FY2015Dec 31, 2015$28.68M+26.0%
FY2014Dec 31, 2014$22.77M+13.0%
FY2013Dec 31, 2013$20.15M-36.8%
FY2012Dec 31, 2012$31.86M-52.8%
FY2011Dec 31, 2011$67.57M+28.3%
FY2010Dec 31, 2010$52.67M+309.7%
FY2009Dec 31, 2009$12.85M+1.9%
FY2008Dec 31, 2008$12.61M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$8.59M+24.8%
Q1 FY2026Mar 31, 2026$15.11M+53.2%
Q4 FY2025Dec 31, 2025$13.10M+263.3%
Q3 FY2025Sep 30, 2025$16.60M+246.7%
Q2 FY2025Jun 30, 2025$6.88M-18.4%
Q1 FY2025Mar 31, 2025$9.87M+206.0%
Q4 FY2024Dec 31, 2024$3.61M-57.8%
Q3 FY2024Sep 30, 2024$4.79M-56.5%
Q2 FY2024Jun 30, 2024$8.44M-22.6%
Q1 FY2024Mar 31, 2024$3.22M-74.7%
Q4 FY2023Dec 31, 2023$8.55M-52.8%
Q3 FY2023Sep 30, 2023$11.01M-45.7%
Q2 FY2023Jun 30, 2023$10.90M-39.8%
Q1 FY2023Mar 31, 2023$12.72M-40.1%
Q4 FY2022Dec 31, 2022$18.12M-1.5%
Q3 FY2022Sep 30, 2022$20.27M-4.8%
Q2 FY2022Jun 30, 2022$18.09M+5.4%
Q1 FY2022Mar 31, 2022$21.24M+47.0%
Q4 FY2021Dec 31, 2021$18.40M+120.5%
Q3 FY2021Sep 30, 2021$21.28M+179.0%
Q2 FY2021Jun 30, 2021$17.16M+85.2%
Q1 FY2021Mar 31, 2021$14.45M-10.0%
Q4 FY2020Dec 31, 2020$8.35M-52.4%
Q3 FY2020Sep 30, 2020$7.63M-54.7%
Q2 FY2020Jun 30, 2020$9.27M+104.5%
Q1 FY2020Mar 31, 2020$16.06M+314.8%
Q4 FY2019Dec 31, 2019$17.55M+233.6%
Q3 FY2019Sep 30, 2019$16.83M+147.3%
Q2 FY2019Jun 30, 2019$4.53M-23.2%
Q1 FY2019Mar 31, 2019$3.87M-59.5%
Q4 FY2018Dec 31, 2018$5.26M+10.0%
Q3 FY2018Sep 30, 2018$6.81M-24.6%
Q1 FY2018Mar 31, 2018$5.90M-10.6%
Q4 FY2017Dec 31, 2017$9.55M-24.2%
Q3 FY2017Sep 30, 2017$4.78M-68.0%
Q2 FY2017Jun 30, 2017$9.03M-55.0%
Q1 FY2017Mar 31, 2017$6.61M–
Q4 FY2016Dec 31, 2016$12.60M–
Q3 FY2016Sep 30, 2016$14.92M–
Q2 FY2016Jun 30, 2016$20.04M–

More Cerenome figures

See a number that looks wrong?